Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in ...
In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...
Most of the genetic risk for developing a substance use disorder comes from genes that broadly affect how our brains process ...
Losing health insurance can quickly worsen health for people with diabetes as patients struggle to control the disease after coverage is interrupted, according to new research from Oregon Health & ...
A national U.S. study links higher ultra-processed food intake to lower odds of fertility, while suggesting that any Mediterranean diet advantage may depend partly on body weight. Study: ...
A drug that is already in clinical trials against hepatitis C virus can also prevent hepatitis E virus from replicating.
Experiencing a sense of loss and sadness after dozens of hours spent on a video game? Researchers from SWPS University and the Stefan Batory Academy of Applied Sciences examined the feeling of ...
Public awareness of the link between drinking alcohol and elevated cancer risk remains unchanged since February 2025, with over half of Americans saying that regularly consuming alcohol increases your ...
The impact of climate change on physical activity patterns poses serious health risks and economic challenges, particularly ...
The study evaluates artificial sweeteners' role in appetite regulation, showing no significant effects on hunger or energy ...
Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...
The Trump administration has signaled a willingness to halt billions of dollars in federal health payments to multiple states ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results